NCT06111300View on ClinicalTrials.gov

Dexmedetomidine Effect on Delirium of Elderly Patients

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

October 31, 2024

Study Completion Date

October 31, 2025

Conditions
Delirium in Old Age
Interventions
DRUG

Dexmedetomidine

Group D (dexmedetomidine group): Patients in this group will receive loading dose of dexmedetomidine 0.7 ug/kg over 10 min. then maintenance dose 0.2 - 1 ug/kg/hr till end of surgery. Group C (control group): Patients in this group will receive volum- matched normal saline infusion (NaCL 0.9%) as a placebo.

All Listed Sponsors
lead

Assiut University

OTHER